What does Tikun Olam-Cannbit Pharmaceuticals Ltd. do?

Tikun Olam-Cannbit Pharmaceuticals Ltd. (TKUN.TA) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is TKUN.TA's market cap?

Tikun Olam-Cannbit Pharmaceuticals Ltd. (TKUN.TA) has a market capitalization of approximately $212,900, as of August 18, 2026, based on the most recent share price and shares outstanding.

Does TKUN.TA pay a dividend?

Yes — Tikun Olam-Cannbit Pharmaceuticals Ltd. (TKUN.TA) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is TKUN.TA profitable?

Tikun Olam-Cannbit Pharmaceuticals Ltd. (TKUN.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

TKUN.TA

Tikun Olam-Cannbit Pharmaceuticals Ltd.

TLV·Drug Manufacturers, Specialty & Generic · Healthcare

ILA 125.30ILA 0.00+0.00%

Market capILA 212.90K·Aug 18 2:24 PM UTC

Price Chart

ILA 125.30+ILA 0.00 (+0.00%)today

−100.00%CAGR −96.46%

Select date range

FromTo

Aug 12, 2002Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

TKUN.TA does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 29

Last Report DateFeb 13

Reported vs Estimate−ILA 2,435.00

Earnings Surprise—

FinancialsFinancials Tab

Revenue₪9.10M

Net Income−₪15.85M

Net Margin−174.2%

Operating Cash Flow₪618.00K

Capital Expenditures₪0.00

Free Cash Flow₪618.00K

Return on Equity—

Return on Invested Capital61.3%

Net Debt₪11.50M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for TKUN.TA and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how TKUN.TA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TKUN.TA and 80,000+ other tickers.

About Tikun Olam-Cannbit Pharmaceuticals Ltd.

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers clinical research, training, and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd was founded in 2006 and is based in Nof HaGalil, Israel.

CEO: Ronen Elad
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: TLV
Employees: 4
Website: www.tikun-olam.org.il

Peers

Peers Tab

IDNT.TA

Identi Healthcare Ltd.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About TKUN.TA

What does Tikun Olam-Cannbit Pharmaceuticals Ltd. do?: Tikun Olam-Cannbit Pharmaceuticals Ltd. (TKUN.TA) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is TKUN.TA's market cap?: Tikun Olam-Cannbit Pharmaceuticals Ltd. (TKUN.TA) has a market capitalization of approximately $212,900, as of August 18, 2026, based on the most recent share price and shares outstanding.
Does TKUN.TA pay a dividend?: Yes — Tikun Olam-Cannbit Pharmaceuticals Ltd. (TKUN.TA) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is TKUN.TA profitable?: Tikun Olam-Cannbit Pharmaceuticals Ltd. (TKUN.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.